# Propafenone

## Rhynorm 150mg

| TAH Drug Code      | [ORHY](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ORHY)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ventricular & supraventricular tachyarrhythmias， Wolff-Parkinson-White syndrome.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Adult (70 kg): Initial and maintenance dose: 450-600 mg/day in 2-3 divided doses. May increase to 900 mg/day. Dosage may be adjusted in patients with lower body weight. Children: 10-20mg/kg/day in 3-4 divided doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | - Known allergy to the main ingredient of this product， propafenone hydrochloride， or any other ingredient. - Known Brugada syndrome (see Warnings and Precautions) - Overt structural heart disease， such as: ˙ Uncontrolled congestive heart failure (left ventricular blood output ratio less than 35%) ˙ Psychogenic shock (except shock due to arrhythmia) - Bradycardia with severe symptoms - sinus node insufficiency， atrial conduction disorder， grade 2 or more severe atrial disorder in the absence of an artificial pacemaker Ventricular block or branch tract block or terminal block - Severe hypotension - Significant electrolyte imbalance (e.g. abnormal potassium metabolism) - Severe obstructive pulmonary disease - Concomitant treatment with ritonavir |
| Adverse Effects    | May induce arrhythmia eg. bradycardia， induction disorder， tachycardia. Rarely ventricular fibrillation. May increase severity of heart failure. Hypotension. GI disturbances. Paresthesia， visual disturbances， dizziness. Rarely fatigue， headache， psychotic disorders. Blood disorders. Rarely， skin allergy， bronchospasm. Cardiovascular: Chest pain (1.8% )， Edema (5% to 13% )， Palpitations (3.4% ) Gastrointestinal: Constipation (8% to 14% )， Nausea (9% to 17% )， Taste sense altered (6% to 22% )， Vomiting (0% to 6% ) Neurologic: Dizziness (21% to 23% ) Psychiatric: Anxiety (10% to 13% ) Respiratory: Dyspnea (13% to 17% )， Upper respiratory infection (8% to 12% ) Other: Fatigue (11% to 13% )                                                   |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/propafenone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

